chr1-181724499-G-C
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PS1_ModeratePM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_001205293.3(CACNA1E):c.2104G>C(p.Ala702Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A702S) has been classified as Pathogenic.
Frequency
Consequence
NM_001205293.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.2104G>C | p.Ala702Pro | missense_variant | 17/48 | ENST00000367573.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.2104G>C | p.Ala702Pro | missense_variant | 17/48 | 1 | NM_001205293.3 | A2 | |
CACNA1E | ENST00000367570.6 | c.2104G>C | p.Ala702Pro | missense_variant | 17/47 | 1 | P4 | ||
CACNA1E | ENST00000621791.4 | c.2104G>C | p.Ala702Pro | missense_variant | 17/46 | 1 | A2 | ||
CACNA1E | ENST00000360108.7 | c.2104G>C | p.Ala702Pro | missense_variant | 17/47 | 5 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2016 | The A702P variantl has not been published as pathogenic, nor has it been reported as a benign variant to our knowledge.The A702P variant was not observed in approximately 6200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. It is a semi-conservative amino acid substitution that occurs at a conserved position within the transmembrane segment S6 of the second homologous domain. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, the A702P variant is likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at